Daliresp (roflumilast)
250 ug/1 · Tablet
By AstraZeneca Pharmaceuticals LP
- NDC
- 0310-0088
- Route
- Oral
- Therapeutic class
- Phosphodiesterase 4 Inhibitor , Phosphodiesterase 4 Inhibitors [MoA]
- Marketing category
- NDA
Package sizes
- 1 BLISTER PACK in 1 BOX, UNIT-DOSE (0310-0088-28) / 28 TABLET in 1 BLISTER PACKNDC 0310-0088-28Available to order
- 10 BLISTER PACK in 1 BOX, UNIT-DOSE (0310-0088-39) / 2 TABLET in 1 BLISTER PACKNDC 0310-0088-39Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

